| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2010920 | Pharmacological Reports | 2014 | 5 Pages |
Abstract
rhIL-24 circumvented the drug-resistance of MCF-7/ADM cells via activation of the transcription factor Stat 3. rhIl24 has potential to act as a P-gp inhibitor to reverse Adriamycin resistance in breast cancer.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Muhammad Imran Amirzada, Xin Ma, Xiaohai Gong, Yun Chen, Sajid Bashir, Jian Jin,